What are other barriers to entry in pharmaceutical industry


Discussion Post I

Prior to beginning work on this discussion, read Ellen Martin's article, The Ethics of Big Data.

Based on the article's content, respond to the following:

i. Describe the microeconomic principles being used. What is the impact for demand?

ii. Evaluate the different market structures that big data benefits the least and the most from.

iii. While data collection may benefit the business community, discuss the concerns for consumers as big data proliferates.

Discussion Post II

Patents are granted for 20 years, but pharmaceutical companies cannot use their patent-guaranteed monopoly powers for anywhere near this long because it takes several years to acquire Food and Drug Adminstration (FDA) approval of drugs.

i. What purposes do barriers to entry created by the government serve?
ii. What are other barriers to entry in the pharmaceutical industry?
iii. Should drug patents be extended to 20 years after FDA approval?
iv. xplain what would be the costs and benefits from this extension.

The response should include a reference list. Using double-space, Times New Roman 12 pnt font, one-inch margins, and APA style of writing and citations.

Solution Preview :

Prepared by a verified Expert
Microeconomics: What are other barriers to entry in pharmaceutical industry
Reference No:- TGS03121612

Now Priced at $20 (50% Discount)

Recommended (90%)

Rated (4.3/5)